Pyk2 dysregulation in temporal lobe epilepsy: insights from human resected tissues and pharmacological modulation in a rodent model
Journal of Neural Transmission · 2026-03 · 133 (3) · 509-527
DOI: 10.1007/s00702-025-03019-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neural Transmission, online erschienen am 06.10.2025. Verfasst von Ozasvi R Shanker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dr. B R Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, India. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Focal Adhesion Kinase 2, Hippocampus, Temporal Lobe. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: University of Delhi.
Abstract (Originalsprache)
Temporal lobe epilepsy (TLE) is a common and often drug-resistant neurological disorder, presenting a major clinical challenge due to the limited effectiveness of current therapies. There is a pressing need to identify novel molecular targets to improve treatment outcomes. This study focuses on Pyk2, a calcium-sensitive non-receptor tyrosine kinase implicated in neuronal signalling and excitability. Given its abundant neural expression and synaptic role, the research investigates Pyk2's spatio-temporal activity and phosphorylation in mesial TLE (MTLE) patients and in a lithium-pilocarpine rat model across acute and chronic stages. Using techniques such as western blotting, qRT-PCR, kinase assays, and FACS, the study also explores the impact of PF-4,618,433, a pharmacological Pyk2 inhibitor. Elevated phosphorylation of Pyk2 at Tyr402 was observed in MTLE patient hippocampi and temporal lobes, correlating with increased intracellular calcium. In rats, Pyk2 activation displayed stage- and region-specific changes, notably extending to cortical areas in chronic TLE. Inhibition of Pyk2 reduced its activity, significantly lowering seizure frequency and intensity. These findings suggest that calcium-driven, temporally regulated Pyk2 activation contributes to TLE pathology. Targeting Pyk2 may represent a promising therapeutic strategy, offering potential for seizure mitigation and network remodeling. Further research is needed to assess long-term effects and refine clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. B R Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, India.
- Department of Clinical Biochemistry, University of Kashmir, Hazratbal, Srinagar, India.
- Department of Biophysics, AIIMS, New Delhi, India.
- Department of Neurology, AIIMS, New Delhi, India.
- Department of Neurosurgery, AIIMS, New Delhi, India.
- Department of Pathology, AIIMS, New Delhi, India.
Förderung
- University of Delhi
Zitieren
APA
Shanker, O. R., Kumar, S., Parrah, K. A., Banerjee, J., Tripathi, M., Chandra, P. S., Sharma, M. C., Doddamani, R., Lalwani, S., Siraj, F., & Dixit, A. B. (2026). Pyk2 dysregulation in temporal lobe epilepsy: insights from human resected tissues and pharmacological modulation in a rodent model. Journal of Neural Transmission, 133(3), 509-527. https://doi.org/10.1007/s00702-025-03019-6
Vancouver
Shanker OR, Kumar S, Parrah KA, Banerjee J, Tripathi M, Chandra PS, et al. Pyk2 dysregulation in temporal lobe epilepsy: insights from human resected tissues and pharmacological modulation in a rodent model. Journal of Neural Transmission. 2026;133(3):509-527. doi:10.1007/s00702-025-03019-6
BibTeX
@article{Shanker2026,
author = {Shanker, Ozasvi R and Kumar, Sonali and Parrah, Kifayat Afzal and Banerjee, Jyotirmoy and Tripathi, Manjari and Chandra, P Sarat and Sharma, M C and Doddamani, Ramesh and Lalwani, Sanjeev and Siraj, Fouzia and Dixit, Aparna Banerjee},
title = {Pyk2 dysregulation in temporal lobe epilepsy: insights from human resected tissues and pharmacological modulation in a rodent model},
journal = {Journal of Neural Transmission},
year = {2026},
volume = {133},
number = {3},
pages = {509--527},
doi = {10.1007/s00702-025-03019-6}
}
EUVIMED